A controlled study of consumption of β-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects

British Journal of Nutrition

Volumn 103, Issue 3, 2010, Pages 422-428

  Cugnet Anceau, Christine ^{a,b,c,d,e,f,h}   Nazare, Julie Anne ^a,b,c,d,e,f   Biorklund, Maria ^g   Le Coquil, Elodie ^h   Sassolas, Agnès ⁱ   Sothier, Monique ^a,b,c,d,e,f   Holm, Jorgen ^j   Landin Olsson, Mona ^k   Önning, Gunilla ^g   Laville, Martine ^a,b,c,d,e,f   Moulin, Philippe ^{a,b,c,d,e,f,h}  

^a Centre de Recherche en Nutrition Humaine de Rhône Alpes   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSERM   (France)

^e UNIVERSITÉ LYON 1   (France)

^f EDOUARD HERRIOT HOSPITAL   (France)

^g LUND UNIVERSITY   (Sweden)

^h LOUIS PRADEL HOSPITAL   (France)

ⁱ Centre de Biologie et Pathologie Est   (France)

^j Findus AB   (Sweden)

^k LUND UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

Glucan; HbA1c; Lipid profile; Long term intervention; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B; BETA GLUCAN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; LIPID; PLACEBO;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DIETARY INTAKE; DIETARY REFERENCE INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; FOOD SAFETY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT CONTENT; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BODY WEIGHT; CARDIOVASCULAR DISEASE; DIABETIC ANGIOPATHY; DIABETIC DIET; DRUG EFFECT; METABOLISM; MIDDLE AGED; OAT; PATHOPHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR;

AGED; AVENA SATIVA; BETA-GLUCANS; BLOOD GLUCOSE; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC DIET; DOUBLE-BLIND METHOD; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MIDDLE AGED; PLACEBOS; QUESTIONNAIRES; RISK FACTORS;

EID: 77449117330     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991875     Document Type: Article

References (28)

1. Salmeron J, Ascherio A, Rimm EB, et al. (1997) Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545-550.
2. Wolk A, Manson JE, Stampfer MJ, et al. (1999) Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 281, 1998-2004.
3. Liu S, Buring JE, Sesso HD, et al. (2002) A prospective study of dietary fiber intake and risk of cardiovascular disease among women. J Am Coll Cardiol 39, 49-56.
4. Braaten JT, Wood PJ, Scott FW, et al. (1991) Oat gum lowers glucose and insulin after an oral glucose load. Am J Clin Nutr 53, 1425-1430.
5. Wursch P & Pi-Sunyer FX (1997) The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care 20, 1774-1780.
6. Brown L, Rosner B, Willett WW, et al. (1999) Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 69, 30-42.
7. Tappy L, Gugolz E & Wursch P (1996) Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 19, 831-834.
8. Lia A, Hallmans G, Sandberg AS, et al. (1995) Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 62, 1245-1251.
9. Keogh GF, Cooper GJ, Mulvey TB, et al. (2003) Randomized controlled crossover study of the effect of a highly beta-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 78, 711-718.
10. Naumann E, van Rees AB, Onning G, et al. (2006) Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 83, 601-605.
11. Battilana P, Ornstein K, Minehira K, et al. (2001) Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 55, 327-333.
12. Wood PJ, Braaten JT, Scott FW, et al. (1994) Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 72, 731-743.
13. Jenkins DJ, Kendall CW, Vuksan V, et al. (2002) Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 75, 834-839.
14. Reyna NY, Cano C, Bermudez VJ, et al. (2003) Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. Am J Ther 10, 438-443.
15. Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
16. Onning G, Wallmark A, Persson M, et al. (1999) Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterole-mia. Ann Nutr Metab 43, 301-309.
17. Torronen R, Kansanen L, Uusitupa M, et al. (1992) Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur J Clin Nutr 46, 621-627.
18. Kerckhoffs DA, Hornstra G & Mensink RP (2003) Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 78, 221-227.
19. Biorklund M, Holm J & Onning G (2008) Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal. Ann Nutr Metab 52, 83-90.
20. Ripsin CM, Keenan JM, Jacobs DR Jr, et al. (1992) Oat products and lipid lowering. A meta-analysis. JAMA 267, 3317-3325.
21. Aro A, Uusitupa M, Voutilainen E, et al. (1981) Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 21, 29-33.
22. Pick ME, Hawrysh ZJ, Gee MI, et al. (1996) Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc 96, 1254-1261.
23. Vuksan V, Jenkins DJ, Spadafora P, et al. (1999) Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 22, 913-919.
24. Braaten JT, Scott FW, Wood PJ, et al. (1994) High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med 11, 312-318.
25. Brennan CS (2005) Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res 49, 560-570.
26. Nazare JA, Normand S, Oste Triantafyllou A, et al. (2008) Modulation of the postprandial phase by beta-glucan in overweight subjects: effects on glucose and insulin kinetics. Mol Nutr Food Res 53, 361-369.
27. Anderson JW, Davidson MH, Blonde L, et al. (2000) Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 71, 1433-1438.
28. Lyly M, Honkapää K, Poutanen K, et al. (2007) Factors influencing consumers' willingness to use beverages and ready-to-eat frozen soups containing oat beta-glucan in Finland. Food Qual Prefer 18, 242-255.